A Focus on Intermediate-Risk Acute Myeloid Leukemia: Sub-Classification Updates and Therapeutic Challenges

SIMPLE SUMMARY: Risk stratification models, including the European LeukemiaNet 2017 and 2022 guidelines, categorize newly diagnosed acute myeloid leukemia (AML) patients into several subgroups of distinct genetic characteristics and disease outcomes. The intermediate-risk group remains the most hete...

Descripción completa

Detalles Bibliográficos
Autores principales: Awada, Hassan, Mustafa Ali, Moaath K., Thapa, Bicky, Awada, Hussein, Seymour, Leroy, Liu, Louisa, Gurnari, Carmelo, Kishtagari, Ashwin, Wang, Eunice, Baer, Maria R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9454629/
https://www.ncbi.nlm.nih.gov/pubmed/36077703
http://dx.doi.org/10.3390/cancers14174166

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9454629/
https://www.ncbi.nlm.nih.gov/pubmed/36077703
http://dx.doi.org/10.3390/cancers14174166

Ejemplares similares